• SHOP
    • COMBOS
    • TESTIMONIALS
    • CART
    • INGREDIENTS
      • 2-DEOXY-D-GLUCOSE (2DG)
      • ACACIA CYANOPHYLLA FLOWER
      • ACORI GRAMINEI RHIZOMA
      • AEGLE MARMELOS CORREA
      • AGARICUS BLAZEI
      • AGED GARLIC EXTRACT
      • AFRAMOMUM MELEGUETA
      • ALOE ARBORESCENS
      • ALBIZIA
      • ALPINIA OFFICINARUM
      • ALTERNANTHERA SESSILIS
      • AMERICAN GINSENG
      • AMYGDALIN
      • ANACYCLUS PYRETHRUM
      • ANGELICA ARCHANGELICA
      • ANGELICA SINENSIS
      • ANTRODIA
      • APIGENIN
      • ARTICHOKE LEAF
      • ARTOCARPIN
      • AJUGA TURKESTANICA
      • ASHWAGANDHA
      • ASPALATHIN
      • ASTRAGALUS COMPLANATUS
      • AVENA SATIVA
      • BACOPA MONNIERI
      • BAVACHIN
      • BEE POLLEN
      • BETULINIC ACID
      • BOSWELLIC ACID
      • BREVILIN A
      • CAMPESTEROL
      • CAPSAICIN
      • CARCININE
      • CASTICIN
      • CHRYSIN
      • CIANIDANOL
      • CINNAMOMUM ZEYLANICUM
      • CITRULLUS COLOCYNTHIS
      • CITRUS RETICULATA PEEL
      • CODONOPSIS
      • CONJUGATED LINOLEIC ACID
      • COSTUNOLIDE
      • CYANIDIN
      • CUCURBITACIN D
      • DAIDZEIN
      • DECURSIN
      • DELPHINIDIN
      • DIGITALIS PURPREA (DIGOXIN)
      • DIOSMIN
      • ELLAGIC ACID
      • EMBELIN
      • ERIODICTYOL
      • GALLIC ACID
      • GLYCITEIN
      • GLYCYRRHIZIN
      • HYPERFORIN
      • ICARIIN
      • ISORHAMNETIN
      • ISOORIENTIN
      • ISOVITEXIN
      • JACEOSIDIN
      • KAEMPFEROL
      • KIGELIA AFRICANA
      • KURARINONE
      • LEMON BALM
      • LICORICIDIN
      • LIPOIC ACID
      • LUPEOL
      • MAGNOLOL
      • MULBERRY LEAF
      • NARINGENIN
      • NOBILETIN
      • OLEACEIN
      • OLEANOLIC ACID
      • OLIVE OIL
      • ORIDONIN
      • PARTHENOLIDE
      • PHLOROGLUCINOL
      • PHLORIZIN
      • PICEATANNOL
      • PRISTIMERIN
      • PROANTHOCYANIDINS
      • PROCYANIDIN B3
      • PSEUDOLARIC ACID B
      • PTEROSTILBENE
      • RUTIN
      • SOLIDAGO VIRGAUREA
      • TANGERETIN
      • TARAXASTEROL
      • TRICHOSTATIN A
      • WEDELOLACTONE
      • WOGONIN
      • YERBA MATE
    • ABOUT
    • SCIENTIFIC STUDIES
      • ADAPTOGENS
      • ADIPOCYTE APOPTOSIS (KILLING FAT CELLS)
      • ADDICTION AND THE BRAIN
      • ADDICTION & STRESS
      • ADDICTION WITHDRAWAL
      • ADIPOCYTE DEDIFFERENTIATION (THE REVERSAL OF FAT FORMATION)
      • ADIPOCYTE DIFFERENTIATION
      • ALLERGIES & CYTOKINES
      • ALDOSTERONE & OBESITY/HYPERTENSION
      • ALZHEIMER’S, DEMENTIA, PARKINSON’S
      • ANTI-ACNE EFFECT OF FLAVONOIDS AND POLYPHENOLS
      • ADVANCED GLYCATION END PRODUCTS (AGES)
      • ADDICTION TREATMENT
      • AMPK
      • ANTI AGING
      • ANTIAGING EFFECTS OF COFFEE
      • ANTI-AGING EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-APOPTOTIC PATHWAYS
      • ANTI ATHEROGENIC
      • ANTI-CANCER EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI CARIOGENIC (Protecting From Tooth Decay)
      • ANTI COVID-19 EFFECTS OF MEDICINAL PLANTS, FLAVONOIDS & POLYPHENOLS
      • ANTI GLYCATIVE
      • ANTI GLYCATION AGENTS
      • ANTI-INFLAMMATORY EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-VIRAL EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI WRINKLE AGENTS
      • APOPTOSIS
      • APOPTOSIS IN 3T3-L1
      • AUTOPHAGY
      • BCL-2
      • BCL-W
      • BCL-XL
      • BDNF
      • BECLIN-1 & AUTOPHAGY
      • BH3 MIMETICS
      • BIM aka BCL2L11
      • BMI-1
      • BRASSINOSTEROIDS
      • CALORIE RESTRICTION
      • CALORIE RESTRICTION & LIFESPAN EXTENSION
      • CARBAMYLATION
      • CARBONYL SCAVENGER
      • CARBONYL STRESS
      • CARDIOPROTECTIVE AGENTS
      • CARDIAC GLYCOSIDES
      • CATALASE
      • CELL CYCLE ARREST
      • CENTENARIANS
      • CHOLESTEROL EFFLUX
      • COGNITIVE ENHANCEMENT
      • COLD SHOCK PROTEINS
      • COLD-INDUCIBLE RNA-BINDING PROTEIN (CIRBP) & DNA REPAIR
      • CONDITIONED PLACE PREFERENCE
      • CORTICOTROPIN RELEASING FACTOR
      • CRYOTHERAPY
      • CRYOLIPOLYSIS: FREEZING FAT TO DEATH
      • CYP2E1
      • CYTOKINES IN PAIN, INFLAMMATION & AGING
      • DAF-16
      • DIABETES & CANCER
      • DIHYDROTESTOSTERONE (DHT)
      • DNA METHYLATION & AGING
      • DNA REPAIR
      • DNA REPAIR VIA FLAVONOIDS & POLYPHENOLS
      • ADDICTION & DOPAMINE
      • DRY FASTING AND FLUID RESTRICTION FASTING
      • DYNORPHIN
      • ELLAGITANNINS
      • ENLARGED HEART AND CARDIOMEGALY
      • EPIGENETIC MODIFIERS
      • EPINEPHRINE
      • ERGOGENIC AGENTS (INCREASE ATHLETIC PERFORMANCE)
      • EXCITOXICITY & THE BRAIN
      • EXTRACELLULAR MATRIX STIFFENING (10TH HALLMARK OF AGING)
      • EXTENDS LIFESPAN
      • EXTINCTION TRAINING
      • FASTING BRAIN
      • FASTING CANCER
      • FASTING & CANCER
      • FASTING MIMICKING DIET
      • FEAR EXTINCTION
      • FGF21
      • FLAVONES
      • GABA (γ-AMINOBUTYRIC ACID)
      • GALLOTANNINS
      • GLUCONEOGENESIS
      • GLUTAMATE & BRAIN
      • GLYCATION
      • KLOTHO
      • FASTING, CALORIE RESTRICTION & EXTENDING LIFESPAN
      • FOXO3
      • FOXO4
      • HALLMARKS OF AGING
      • HEPATOPROTECTIVE AGENTS (KEEPING LIVER HEALTHY)
      • HMGB1
      • HORMESIS
      • HPA AXIS
      • HSP70, THE ANTI-AGING PROTEIN
      • HSP90 INHIBITORS
      • HYPERGLYCEMIA
      • HYPERINSULINEMIA
      • HYPOACTIVE SEXUAL DESIRE (WHY PEOPLE HAVE ZERO SEX DRIVE)
      • HYPOCRETIN OREXIN
      • IKK
      • IL-6/STAT3
      • IRISIN
      • ISOFLAVONES
      • IMMUNOSENESCENCE
      • INCREASE PROTEIN SYNTHESIS
      • INFECTOBESITY
      • INFLAMMATION & ANXIETY
      • INFLAMMATION & CANCER
      • INFLAMMATION & DEPRESSION
      • INFLAMMATION & OBESITY
      • INFLAMMAGING
      • INHIBITION OF RENAL GLUCOSE REABSORPTION
      • INSULIN & AGING
      • INSULIN & CANCER: HOW INSULIN LITERALLY PROTECTS CANCER CELLS FROM BEING KILLED
      • INSULIN & MTOR
      • INSULIN & OBESITY
      • INTERMITTENT FASTING
      • JAK INHIBITION ALLEVIATES SASP
      • JNK ACTIVATION PREVENTS PREMATURE SENESCENCE
      • KETONE BODIES
      • KETOGENIC DIET
      • LEYDIG CELL STEROIDOGENESIS
      • LIFESPAN EXTENSION
      • LIPOLYTIC AGENTS
      • LIPID DROPLETS
      • LIPOLYSIS (THE DECOMPOSITION OF BODY FAT)
      • LOWERING CHOLESTEROL THRU FASTING, DIET & MEDICINAL PLANTS
      • MATRIX METALLOPROTEINASES (MMPs)
      • MCL-1
      • MDM2 INHIBITION AS SASP INHIBITOR
      • MEDITERRANEAN DIET
      • MENAQUINONE 4
      • METABOLIC REPROGRAMMING
      • METABOLIC SYNDROME EXTRACT
      • METHIONINE RESTRICTION
      • MITOCHONDRIAL UNCOUPLING
      • MONKEYPOX
      • MSG (MONOSOSODIUM GLUTAMATE)
      • MUSCLE FORCE PRODUCTION
      • MUSCLE ATROPHY (PREVENTING)
      • MYOGENESIS
      • MYOSTATIN INHIBITION
      • MYOSTATIN INHIBITION PRESERVES MUSCLE
      • mTORC2
      • mTOR: THE RAPID AGING PATHWAY
      • NATURAL ANTICOAGULANTS
      • NATURAL AROMATASE INHIBITORS
      • NEUROGENESIS (GROWING NEW BRAIN CELLS)
      • NEUROCHEMISTRY OF ADDICTION
      • NEUROPLASTICITY
      • NEUROINFLAMMATION
      • NEUROPROTECTIVE AGENTS
      • NMDA & ANXIETY & DEPRESSION
      • NMDA RECEPTOR AND FEAR
      • NON-OPIOID ANALGESICS (PLANT BASED)
      • NOOTROPICS
      • NORADRENERGIC
      • NOREPINEPHRINE
      • NRF2: MASTER REGULATOR OF THE AGING PROCESS
      • NF-KB
      • ONCOGENE ACTIVATION INDUCED SENESCENCE
      • OVERNUTRITION
      • OXIDATIVE STRESS & AGING
      • P16INK4A
      • P38MAPK
      • P53: TUMOR SUPRESSOR
      • PERIODONTITIS
      • PHYTOCHEMICALS
      • PHYTOSTEROLS
      • PHYTOSTANOLS
      • PHYTOECDYSTEROIDS
      • PROANTHOCYANIDINS
      • PROTEIN CARBONYLATION
      • POLYAMINES & THEIR EFFECT ON BRAIN (NMDA, DEPRESSION, SUICIDE RISK)
      • PPARY2
      • PREMATURE SENESCENCE
      • PREVENTING SKIN AGING
      • PUFAS
      • PURGATIVES
      • RAPAMYCIN (MTOR INHIBITION)
      • RECEPTOR “Κ OPIOID”
      • RED WINE
      • RENAL (KIDNEY) PROTECTIVE AGENTS
      • REMINERALIZATION OF TEETH
      • REPAIR OF DNA BREAKS “DOUBLE STRAND”
      • RESTORE INSULIN SENSITIVITY
      • SASP & ADIPOSE TISSUE
      • SENESCENT CELLS, SASP & SENOLYTICS
      • SENESCENCE-BETA-GALACTOSIDASE (SA-β-gal or SABG)
      • SGLT2 INHIBITORS
      • SGLT2 INHIBITION FOR LIFESPAN EXTENSION
      • SHBG
      • SIRT1
      • SKELETAL MUSCLE HYPERTROPHY (THE SCIENCE OF BUILDING MUSCLE)
      • SKIN ELASTICITY
      • SKIN PHOTOAGING (Preventing & Repairing)
      • SLEEP DEPRIVATION AS THERAPY FOR DEPRESSION
      • SIRT1 & LONGEVITY
      • SMALLPOX
      • SUGAR & AGING
      • STAR PROTEIN
      • STAT3
      • STEM CELL EXHAUSTION
      • STEM CELL REGENERATION
      • STEM CELL THERAPY
      • STIMULATED LIPOLYSYS
      • STEROIDOGENESIS (THE PRODUCTION OF HORMONES IN BODY)
      • STREPTOCOCCUS MUTANS (MAIN BACTERIA BEHIND TOOTH DECAY)
      • STRESS & AGING
      • STRESS & THE BRAIN
      • TELOMERE SHORTENING & PREMATURE AGING
      • TIME RESTRICTED FEEDING
      • TRAUMATIC BRAIN INJURY (HEALING)
      • TRYPTOPHAN HYDROXYLASE 2
      • VISCERAL ADIPOSITY
    • HOME
    • CONTACT
    • INTERSTELLAR 88/8: EXTREME WEIGHTLOSS PROTOCOL
    • The Ultimate Dry Fasting Resource
    0
    KIGELIA AFRICANA
    February 23, 2021
    ADIPOCYTE APOPTOSIS (KILLING FAT CELLS)
    February 23, 2021
    1. A better parameter in predicting insulin resistance: obesity plus elevated alanine aminotransferase
    2. A case of familial Bardet-Biedl syndrome (obesity, slight mental retardation, polydactyly, retinitis pigmentosum and renal failure) with insulin-resistant diabetes mellitus
    3. A case of insulin autoimmune syndrome that developed after topiramate anti-obesity medication
    4. A central role for JNK in obesity and insulin resistance
    5. A clinically confirmed family history for early myocardial infarction is associated with increased risk of obesity, insulin resistance and metabolic syndrome
    6. A combination of circulating chemokines as biomarkers of obesity‐induced insulin resistance at puberty
    7. A comparison of the relative effects of obesity and non-insulin-dependent diabetes mellitus on in vivo insulin-stimulated glucose utilization
    8. A CONNECTION BETWEEN insulin RESISTANCE AND ANDROGENS, INDEPENDENT OF obesity?
    9. A cross-sectional study of the phenotypes of obesity and insulin resistance in adults with down syndrome.
    10. A Distinct Population of Lipid Sensing iNKT Cells are Enriched in Fat and Protect Against Diet-Induced obesity and insulin Resistance (176.26)
    11. A free-choice high-fat high-sugar diet induces glucose intolerance and insulin unresponsiveness to a glucose load not explained by obesity
    12. A functional GNAQ promoter haplotype is associated with altered Gq expression and with insulin resistance and obesity in women with polycystic ovary syndrome
    13. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome
    14. A high alanine aminotransferase/aspartate aminotransferase ratio determines insulin resistance and metabolically healthy/unhealthy obesity in a general adult …
    15. A high omega-6 PUFA diet impairs hepatocyte insulin signalling during diet-induced obesity
    16. A high ratio of dietary n-3/n-6 polyunsaturated fatty acids improves obesity-linked inflammation and insulin resistance through suppressing activation of TLR4 in SD …
    17. A high-sugar diet produces obesity and insulin resistance in wild-type Drosophila
    18. A ketogenic diet reduces central obesity and serum insulin in women with ovarian or endometrial cancer
    19. A lower duodenal immune response is associated with an increase of insulin resistance in patients with morbid obesity
    20. A major locus for fasting insulin concentrations and insulin resistance on chromosome 6q with strong pleiotropic effects on obesity-related phenotypes in …
    21. A major role of insulin in promoting obesity-associated adipose tissue inflammation
    22. A major role of insulin in promoting obesity-associated adipose tissue inflammation
    23. A Meta-analysis of Effects of Aerobic Exercise on Glucose and insulin in Overweight/obesity Children and Adolescent [J]
    24. A Meta-Analysis of the Impact of obesity, Metabolic Syndrome, insulin Resistance, and Microbiome on the Diagnosis of Barrett’s Esophagus
    25. A microRNA screen reveals that elevated hepatic ectodysplasin A expression contributes to obesity-induced insulin resistance in skeletal muscle
    26. A mitochondrially encoded hormone ameliorates obesity and insulin resistance
    27. A mouse model of diet-induced obesity and insulin resistance
    28. A multidisciplinary intervention in childhood obesity acutely improves insulin resistance and inflammatory markers independent from body composition
    29. A Multiplatform Non-targeted Metabolomics Approach to Investigate insulin Resistance Associated to obesity in Childhood
    30. A muscle-specific UBE2O/AMPKα2 axis promotes insulin resistance and metabolic syndrome in obesity
    31. A new endoscopically implantable device (SatiSphere) for treatment of obesity—efficacy, safety, and metabolic effects on glucose, insulin, and GLP-1 levels
    32. A new link between skeleton, obesity and insulin resistance: relationships between osteocalcin, leptin and insulin resistance in obese children before and after weight …
    33. A new paradigm for diabetes and obesity: the hepatic insulin sensitizing substance (HISS) hypothesis
    34. A new tumor necrosis factor (TNF)-α regulator, lipopolysaccharides-induced TNF-α factor, is associated with obesity and insulin resistance
    35. A non-invasive marker of insulin resistance in patients with obesity
    36. A novel approach to childhood obesity: circulating chemokines and growth factors as biomarkers of insulin resistance
    37. A novel GPCR messenger mediating cholinergic stimulation of synaptotagmin-dependent insulin exocytosis and obesity
    38. A novel IKKβ inhibitor stimulates adiponectin levels and ameliorates obesity-linked insulin resistance
    39. A novel role for insulin resistance in the connection between obesity and postmenopausal breast cancer
    40. A pharmacologic sympathectomy prevents the development of obesity and insulin resistance in the high fat fed rat
    41. A polymorphic variant of the insulin-like growth factor type I receptor gene modifies risk of obesity for esophageal adenocarcinoma
    42. A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp …
    43. A post-weaning obesogenic diet exacerbates the detrimental effects of maternal obesity on offspring insulin signaling in adipose tissue
    44. A post-weaning obesogenic diet exacerbates the detrimental effects of maternal obesity on offspring insulin signaling in adipose tissue
    45. A Potential New Treatment Option for Asthma in the Setting of obesity or insulin Resistance?
    46. A potential role for insulin treatment during pregnancy in reducing postpartum psychological distress in maternal obesity: An administrative population health …
    47. A preliminary study of insulin resistance in essential hypertension, simple obesity and acromegaly
    48. A preliminary study of mechanism of periodontitis and periodontal therapy influence in insulin resistance for obesity rats
    49. A prospective observational study of obesity, body composition, and insulin resistance in 18 women with bipolar disorder and 17 matched control subjects
    50. A randomized control trial of the impact of LCPUFA‐ω3 supplementation on body weight and insulin resistance in pubertal children with obesity
    51. A review of obesity, insulin resistance, and the role of exercise in breast cancer patients
    52. A review of the carbohydrate–insulin model of obesity
    53. A role for 5-lipoxygenase products in obesity-associated inflammation and insulin resistance
    54. A role for EP3 and its associated G protein, Gz, in negatively regulating beta-cell function and mass in the context of insulin resistance and obesity
    55. A role of lipin in human obesity and insulin resistance: relation to adipocyte glucose transport and GLUT4 expression
    56. A simple and effective model to study insulin resistance in obesity and diabetes and the processes and mechanisms of in vitro aging using lymphocyte culture
    57. A simplified method using somatostatin to assess in vivo insulin resistance over a range of obesity
    58. A study of association of sex hormones with insulin resistance and obesity for diabetes mellitus risk in adult women
    59. A Study on insulin Resistance and obesity Among Women at High Risk for Breast Cancer Using Cluster Analysis.
    60. A study on relation of obesity to serum lipid, leptin and insulin concentration in elementary schoolchildren
    61. A study on the genetics of obesity: influence of polymorphisms of the beta-3-adrenergic receptor and insulin receptor substrate 1 in relation to weight loss, waist to hip …
    62. A study on the relationship between neck circumference and obesity related indexes and metabolic disorders associated with insulin resistance
    63. A Submaximal Exercise Patterns Intervention on the Plasmatic Leptin Level and insulin Resistance for Overweight/obesity Boys Adolescences
    64. A three-year follow-up study on risk factors for obesity and non-insulin dependent diabetes mellitus in aging populations in China
    65. A twenty-first century cancer epidemic caused by obesity: the involvement of insulin, diabetes, and insulin-like growth factors
    66. A Uniform. Approach in the Use of U-500 Regular insulin in the Management Of Paiients with obesity and Insu] in Resistance: The Clinicia’s View.
    67. A vast genomic deletion in the C56BL/6 genome affects different genes within the Ifi200 cluster on chromosome 1 and mediates obesity and insulin resistance
    68. AB0025 Is Abatacept Successful in Improving insulin Resistance in A High Fat Diet Model of obesity?
    69. AB0092 Effect of methotrexate, leflunomide and hydroxychloroquine on the insulin resistance and obesity associated with rheumatoid arthritis: obese mouse models …
    70. AB1098 obesity and insulin resistance in fibromyalgia patients
    71. ABCA1 and metabolic syndrome; a review of the ABCA1 role in HDL-VLDL production, insulin-glucose homeostasis, inflammation and obesity
    72. Abdominal obesity and insulin resistance after an episode of acute pancreatitis
    73. Abdominal obesity and insulin resistance in patients with type 2 diabetes in a Swedish community: Skaraborg Hypertension and Diabetes Project
    74. Abdominal obesity and insulin resistance in patients with type 2 diabetes in a Swedish community. Skaraborg hypertension and diabetes project.
    75. Abdominal obesity and insulin resistance in people exposed to moderate-to-high levels of dioxin
    76. Abdominal obesity and low physical activity are associated with insulin resistance in overweight adolescents: a cross-sectional study
    77. Abdominal obesity as a mediator of the influence of physical activity on insulin resistance in Spanish adults
    78. Abdominal obesity as important component of insulin-resistance syndrome.
    79. Abdominal obesity associated with elevated serum Butyrylcholinesterase activity, insulin resistance and reduced high density lipoprotein-cholesterol levels
    80. Abdominal obesity in BTBR male mice is associated with peripheral but not hepatic insulin resistance
    81. Abdominal obesity in older women: potential role for disrupted fatty acid reesterification in insulin resistance
    82. Abdominal obesity is associated with insulin resistance and reduced glycogen synthase activity in skeletal muscle
    83. Abdominal obesity is associated with insulin resistance.
    84. Abdominal obesity Predicts Declining insulin Sensitivity in Non-Obese Normoglycemics
    85. Abdominal obesity predicts declining insulin sensitivity in non‐obese normoglycaemics: the insulin Resistance Atherosclerosis Study (IRAS)
    86. ABDOMINAL obesity, DYSLIPIDEMIA, insulin RESISTANCE, TYPE 2 DIABETES AND ATHEROSCLEROSIS: WHO IS THE RIGHT PATIENT TO BE …
    87. Abdominal obesity, fatty acids and insulin resistance
    88. Abdominal obesity, impaired nonesterified fatty acid suppression, and insulin-mediated glucose disposal are early metabolic abnormalities in families with premature …
    89. Abdominal obesity, insulin resistance and hypertension: impact on left ventricular mass and function in women
    90. Abdominal obesity, insulin resistance, and alterations in hemostasis
    91. Abdominal obesity, insulin resistance, and cardiovascular risk in pre-diabetes and type 2 diabetes
    92. Abdominal obesity, insulin resistance, and colon carcinogenesis are increased in mutant mice lacking gastrin gene expression
    93. Abdominal obesity, insulin resistance, and metabolic syndrome in a southern European population
    94. Abdominal obesity, insulin resistance, and the metabolic syndrome: contribution of physical activity/exercise
    95. Abdominal obesity, insulin resistance, and the risk of colonic adenoma
    96. Abdominal obesity, insulin resistance, metabolic syndrome and cholesterol homeostasis
    97. ABDOMINAL obesity, METABOLIC SYNDROME AND insulin RESISTANCE: PP. 26.340
    98. Abdominal obesity, muscle composition, and insulin resistance in premenopausal women
    99. Abdominal subcutaneous adipose tissue gene expression in relation to tissue-specific insulin resistance in human obesity
    100. Aberrant expression of miR-214 is associated with obesity-induced insulin resistance as a biomarker and therapeutic
    101. Aberrant hepatic expression of PPARγ2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis
    102. Ablation of insulin-producing cells prevents obesity but not premature mortality caused by a high-sugar diet in Drosophila
    103. Ablation of MARK4, an AMPK-related Kinase, Leads to insulin Hypersensitivity and Resistance to Diet-induced obesity
    104. Ablation of TRIP-Br2, a regulator of fat lipolysis, thermogenesis and oxidative metabolism, prevents diet-induced obesity and insulin resistance
    105. Abnormal liver function and insulin resistance in obesity
    106. Abnormal mitochondrial metabolism in obesity and insulin resistance
    107. Abnormalities of Glucose and insulin Metabolism in Exogenous obesity.
    108. Abnormalities of islet B-cell function, insulin action, and fat distribution in women with histories of gestational diabetes: relationship to obesity
    109. Abnormalities of the hypothalamic-pituitary-adrenal axis in nondepressed women with abdominal obesity and relations with insulin resistance: evidence for a central …
    110. Abrogation of toll-like receptor 4 mitigates obesity-induced oxidative stress, proinflammation, and insulin resistance through metabolic reprogramming of mitochondria …
    111. Absence of GIP secretion alleviates age-related obesity and insulin resistance
    112. ABSENCE OF GUT MICROBIOTA PROTECTS AGAINST DIET-INDUCED obesity AND insulin-RESISTANCE BUT PREDISPOSES TO LIVER DAMAGE
    113. Absence of S6K1 protects against age-and diet-induced obesity while enhancing insulin sensitivity
    114. Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lepob/Lepob mice
    115. Absence of the ROS Scavenger DJ-1 Paradoxically Protects Mice from obesity and insulin Resistance
    116. Absence of toll‐like receptor‐2 (Tlr2) attenuates diet induced obesity and adipose tissue inflammation and insulin resistance
    117. Abstract CN13-04: obesity, insulin resistance, hyperglycemia, and cancer: A novel role for metformin as an anticancer drug
    118. Abstract KN01: Keynote Lecture: PI 3-kinase links obesity, insulin resistance, and cancer
    119. Abstract MP55: DNA methylation mediates the effects of obesity on insulin resistance in african american youth and young adults
    120. Abstract P034: Association between obesity Indices and insulin Resistance among Healthy Korean Adolescents
    121. Abstract P088: obesity, Hypertension and insulin Resistance in a Primary Pediatric Setting in Southern Italy
    122. Abstract P438: Staying Active improves insulin Resistance independent of the Metabolic Syndrome and obesity
    123. Abstract P636: insulin Resistance in obesity Results in Postprandial Salt and Water Loss
    124. Abstract WP132: Relationship Of Neck Circumference And insulin Resistance On The Cerebrovascular Reactivity In Subjects With obesity.
    125. Acanthosis nigricans and obesity: acquired and intrinsic defects in insulin action
    126. Acanthosis nigricans as a composite marker of cardiometabolic risk and its complex association with obesity and insulin resistance in Mexican American …
    127. Acanthosis nigricans in obese children and adolescents in relation to severity of obesity and insulin resistance.
    128. Acanthosis nigricans with severe obesity, insulin resistance and hypothyroidism: improvement by diet control
    129. ACANTHOSIS NIGRICANS, obesity, insulin RESISTANCE AND HYPERANDROGENEMIA: NATURAL HISTORY AND PEDIATRIC PERSPECTIVE
    130. Acanthosis nigricans: A valid clinical marker of insulin resistance in obesity
    131. Acetylsalicylic acid modulates inflammation and insulin resistance in a mouse model of diet-induced obesity
    132. Acquired obesity Changes Adipose Tissue MRNA Expression, Increases Abdominal and Liver Fat, and Causes insulin Resistance in Monozygotic Twins
    133. Acquired obesity is associated with increased liver fat, intra-abdominal fat, and insulin resistance in young adult monozygotic twins
    134. ACSL1 multi‐tissue knockout mice are resistant to diet‐and age‐induced obesity and insulin resistance
    135. Activated glucose-6-phosphate dehydrogenase is associated with insulin resistance by upregulating pentose and pentosidine in diet-induced obesity of rats
    136. Activating transcriptional factor 4 correlated with obesity and insulin resistance in polycystic ovary syndrome
    137. Activation and regulation of the pattern recognition receptors in obesity-induced adipose tissue inflammation and insulin resistance
    138. Activation of calcium/calmodulin-dependent protein kinase II in obesity mediates suppression of hepatic insulin signaling
    139. Activation of malonyl‐CoA/fatty acid synthase axis is an early event in the effects of insulin in human skeletal muscle myotubes: Implication for obesity linked insulin …
    140. Activation of placental insulin and mTOR signaling in a mouse model of maternal obesity associated with fetal overgrowth
    141. Activation of the Cbl insulin signaling pathway in cardiac muscle; dysregulation in obesity and diabetes
    142. Activation of the cholinergic antiinflammatory pathway ameliorates obesity-induced inflammation and insulin resistance
    143. Activation of vascular protein kinase C-β inhibits Akt-dependent endothelial nitric oxide synthase function in obesity-associated insulin resistance
    144. Activation of α7nAChR via vagus nerve prevents obesity-induced insulin resistance via suppressing endoplasmic reticulum stress-induced inflammation in Kupffer …
    145. Activity of tamarindus indica pulp water extract in high carbohydrate diet rats as a treatment for obesity and insulin resistance
    146. Acupuncture for Treatment of obesity and insulin Resistance
    147. Acupuncture targeting SIRT1 in the hypothalamic arcuate nucleus can improve obesity in high-fat-diet-induced rats with insulin resistance via an anorectic effect
    148. Acute insulin infusion decreases plasma ghrelin levels in uncomplicated obesity
    149. Acute regulation of insulin release by the pituitary gland in relation to hyperinsulinaemia and obesity
    150. Acylcarnitine kinetics in a fasting-and obesity-induced insulin resistant mouse model
    151. Adapter proteins regulate insulin resistance and lipid metabolism in obesity
    152. Adapting to insulin resistance in obesity: role of insulin secretion and clearance
    153. Adaptive immunity and antigen-specific activation in obesity-associated insulin resistance
    154. Adaptive immunity in obesity and insulin resistance
    155. ADAR1 deficiency protects against high-fat diet-induced obesity and insulin resistance in mice
    156. Added impact of obesity and insulin resistance in nocturnal blood pressure elevation in children and adolescents
    157. Additive effects of obesity, hypertension, and type 2 diabetes on insulin resistance.
    158. Adenosine Triphosphate-Sensitive Potassium (KATp) Channel Activity Is Coupled with insulin Resistance in obesity and
    159. Adenovirus-36 seropositivity enhances effects of nutritional intervention on obesity, bright liver, and insulin resistance
    160. Adenylyl cyclase 3 haploinsufficiency confers susceptibility to diet-induced obesity and insulin resistance in mice
    161. Adenylyl cyclase type 5 deficiency protects against diet-induced obesity and insulin resistance
    162. Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis
    163. Adipocyte CD1d determines adipose inflammation and insulin resistance in obesity
    164. Adipocyte CREB promotes insulin resistance in obesity
    165. Adipocyte DIO2 expression increases in human obesity but is not related to systemic insulin sensitivity
    166. Adipocyte dysfunction, inflammation, and insulin resistance in obesity
    167. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes
    168. Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in …
    169. Adipocyte insulin resistance: effects of aging, obesity, exercise, and food restriction
    170. Adipocyte protein carbonylation and oxidative stress in obesity-linked mitochondrial dysfunction and insulin resistance.
    171. Adipocyte SIRT1 knockout promotes PPARγ activity, adipogenesis and insulin sensitivity in chronic-HFD and obesity
    172. Adipocyte-specific CD1d-deficiency mitigates diet-induced obesity and insulin resistance in mice
    173. Adipocyte-specific deficiency of NADPH oxidase 4 delays the onset of insulin resistance and attenuates adipose tissue inflammation in obesity
    174. Adipocyte-specific DKO of Lkb1 and mTOR protects mice against HFD-induced obesity, but results in insulin resistance
    175. Adipocyte‐specific enhancement of angiotensin II type 1 receptor‐associated protein ameliorates diet‐induced visceral obesity and insulin resistance
    176. Adipocytes secrete leukotrienes: contribution to obesity-associated inflammation and insulin resistance in mice
    177. Adipocytokine profile and insulin resistance in childhood obesity
    178. Adipocytokines and insulin levels in young obese subjects at risk for type II diabetes–the STYrian Juvenile obesity Study (STYJOBS)
    179. Adipocytokines, insulin resistance and obesity coherence in women with previously diagnosed gestational diabetes
    180. Adipocytokines, obesity, and insulin resistance during combined androgen blockade for prostate cancer
    181. Adipocytokines: a bridge connecting obesity and insulin resistance
    182. Adipogenesis and insulin sensitivity in obesity are regulated by retinoid‐related orphan receptor gamma
    183. Adipogenic miR-27a in adipose tissue upregulates macrophage activation via inhibiting PPARγ of insulin resistance induced by high-fat diet-associated obesity
    184. ADIPOKINE PROFILES OFinsulin SENSITIVE obesityAND insulin RESISTANCE obesity AMONG CHINESE CHILDREN: THE BCAMS STUDY
    185. Adipokines as Novel Links between obesity and insulin Resistance
    186. Adipokines, Ghrelin and obesity‐Associated insulin Resistance in Nondiabetic Patients with Acute Coronary Syndrome
    187. Adipokines, inflammation, and insulin resistance in obesity
    188. Adipokines, systemic inflammation and inflamed adipose tissue in obesity and insulin resistance
    189. Adipokines: the missing link between insulin resistance and obesity
    190. Adiponectin and adiponectin receptors in obesity-linked insulin resistance
    191. Adiponectin and insulin resistance in childhood obesity
    192. Adiponectin and insulin resistance in obesity-related diseases
    193. Adiponectin and insulin resistance responses to aerobic training in males with abdominal obesity
    194. Adiponectin and its potential in the treatment of obesity, diabetes and insulin resistance.
    195. Adiponectin and its role in the obesity-induced insulin resistance and related complications
    196. Adiponectin and its role in the pathogenesis of obesity, diabetes mellitus and insulin resistance
    197. Adiponectin as novel biomarker of endothelial dysfunction in insulin resistance and obesity–a narrative review
    198. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-α expression
    199. Adiponectin expression in visceral adiposity is an important determinant of insulin resistance in morbid obesity
    200. Adiponectin Gene Variation-4522C/T Is Associated with Type 2 Diabetic obesity and insulin Resistance in Chinese
    201. Adiponectin gene variation− 4522C/T is associated with type 2 diabetic obesity and insulin resistance in Chinese
    202. Adiponectin, anthropometric measurements and insulin resistance in adolescence with obesity.
    203. Adiponectin, the missing link in insulin resistance and obesity
    204. Adiponectin: a biomarker of obesity-induced insulin resistance in adipose tissue and beyond
    205. Adiponectin: A Mediator of obesity, insulin Resistance, Diabetes, and the Metabolic Syndrome
    206. Adiponectin: a new link between obesity, insulin resistance and cardiovascular disease
    207. ADIPOSE AND INTESTINAL IMMUNOPATHOLOGY IN obesity RELATED insulin RESISTANCE.
    208. Adipose cell and lipid turnovers in obesity and insulin resistance
    209. Adipose dipeptidyl peptidase-4 and obesity: correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro
    210. Adipose DPP4 and obesity: correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro
    211. Adipose Estrogen and Increased Breast Cancer Risk in obesity: Regulation by Leptin and insulin
    212. Adipose Expression and Regulation of Selenoprotein P in obesity and insulin Resistance
    213. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance
    214. Adipose extracellular matrix remodelling in obesity and insulin resistance
    215. Adipose HuR protects against diet-induced obesity and insulin resistance
    216. Adipose HuR protects against diet-induced obesity and insulin resistance in mice
    217. Adipose hypothermia in obesity and its association with period homolog 1, insulin sensitivity, and inflammation in fat
    218. Adipose inflammation: cause or consequence of obesity-related insulin resistance
    219. Adipose natural killer cells regulate adipose tissue macrophages to promote insulin resistance in obesity
    220. Adipose overexpression of phosphoenolpyruvate carboxykinase leads to high susceptibility to diet-induced insulin resistance and obesity
    221. Adipose tissue adiponectin production and adiponectin serum concentration in human obesity and insulin resistance
    222. Adipose tissue and insulin secretion in the pathophysiology of obesity and its complications
    223. Adipose tissue as a source of proinflammatory factors in obesity: The importance in the development of insulin resistance and diabetes
    224. Adipose tissue dendritic cells are independent contributors to obesity-induced inflammation and insulin resistance
    225. Adipose tissue extracellular matrix and vascular abnormalities in obesity and insulin resistance
    226. Adipose tissue fatty acid chain length and mono-unsaturation increases with obesity and insulin resistance
    227. Adipose tissue gene expression of CXCL10 and CXCL11 modulates inflammatory markers in obesity: implications for metabolic inflammation and insulin resistance
    228. Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines
    229. Adipose tissue inflammation and systemic insulin resistance in mice with diet-induced obesity is possibly associated with disruption of PFKFB3 in hematopoietic cells
    230. Adipose tissue inflammation is directly linked to obesity-induced insulin resistance, while gut dysbiosis and mitochondrial dysfunction are not required
    231. Adipose tissue inflammation: a cause or consequence of obesity-related insulin resistance?
    232. Adipose tissue insulin resistance due to loss of PI3K p110α leads to decreased energy expenditure and obesity
    233. Adipose tissue lymphocytes and macrophages in obesity and insulin resistance: makers or markers, and which comes first?
    234. Adipose tissue macrophage phenotypes and characteristics: the key to insulin resistance in obesity and metabolic disorders
    235. Adipose tissue macrophage-derived exosomal miR-29a regulates obesity-associated insulin resistance
    236. Adipose tissue macrophages in the development of obesity-induced inflammation, insulin resistance and type 2 diabetes
    237. Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity
    238. Adipose tissue monomethyl branched‐chain fatty acids and insulin sensitivity: Effects of obesity and weight loss
    239. Adipose tissue mRNA expression of HDAC1, HDAC3 and HDAC9 in obese women in relation to obesity indices and insulin resistance
    240. Adipose tissue NAD+ biology in obesity and insulin resistance: From mechanism to therapy
    241. Adipose tissue natriuretic peptide receptor expression is related to insulin sensitivity in obesity and diabetes
    242. Adipose Tissue Overexpression of a Constitutively Active Isoform of Chrebp Protects Against obesity and insulin Resistance in Mice
    243. Adipose tissue overexpression of vascular endothelial growth factor protects against diet-induced obesity and insulin resistance
    244. Adipose Tissue Secretory Changes and Low-Grade Inflammation Combine With insulin Resistance and Vascular Dysfunction in Human obesity
    245. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance
    246. Adipose tissue transplantation protects ob/ob mice from obesity, normalizes insulin sensitivity and restores fertility
    247. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance
    248. Adipose Tissue VEGF‐D Overexpression Increases Lymphatic Vessel Density and Protects Against Inflammation and insulin Resistance in obesity
    249. Adipose tissue, but not skeletal muscle, sirtuin 1 expression is decreased in obesity and related to insulin sensitivity
    250. Adipose TNF and IL-6 expression in human obesity-associated insulin resistance
    251. Adipose-resident group 1 innate lymphoid cells promote obesity-associated insulin resistance
    252. Adipose-specific deficiency of fumarate hydratase in mice protects against obesity, hepatic steatosis, and insulin resistance
    253. Adipose-specific deletion of TFAM increases mitochondrial oxidation and protects mice against obesity and insulin resistance
    254. Adipose-specific knockdown of Sirt1 results in obesity and insulin resistance by promoting exosomes release
    255. Adipose-specific knockout of ubiquitin-conjugating enzyme E2L6 (Ube2l6) reduces diet-induced obesity, insulin resistance, and hepatic steatosis
    256. Adipose‐specific deletion of Kif5b exacerbates obesity and insulin resistance in a mouse model of diet‐induced obesity
    257. Adiposity in childhood predicts obesity and insulin resistance in young adulthood
    258. Adolescent Metabolic/Bariatric Surgery: Effects on obesity, Comorbidities, and insulin Resistance
    259. Adolescent obesity and insulin resistance: roles of ectopic fat accumulation and adipose inflammation
    260. Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity
    261. Adrenomedullin 2 improves early obesity-induced adipose insulin resistance by inhibiting the class II MHC in adipocytes
    262. Adult-onset obesity reveals prenatal programming of glucose-insulin sensitivity in male sheep nutrient restricted during late gestation
    263. Adverse effects of obesity on lipid and lipoprotein levels in insulin-dependent and non-insulin-dependent diabetes
    264. Adverse effects of obesity on lipid and lipoprotein levels in the patients with non-insulin dependent diabetes in the young
    265. Adverse Effects of obesity, Hyperglycemia, and insulin Resistance on Cardiac Mechanics
    266. Aerobic Exercise Training Prevents obesity and insulin Resistance Independent of Changes in the Skeletal Muscle ACE2/Ang 1‐7/Mas Axis.
    267. Aerobic exercise training prevents obesity and insulin resistance independent of the renin angiotensin system modulation in the subcutaneous white adipose …
    268. Age-associated increase in abdominal obesity and insulin resistance, and usefulness of AHA/NHLBI definition of metabolic syndrome for predicting cardiovascular …
    269. Aging enhances the insulin resistance in obesity through both receptor and postreceptor alterations
    270. AKAP1 Deficiency Attenuates Diet‐Induced obesity and insulin Resistance by Promoting Fatty Acid Oxidation and Thermogenesis in Brown Adipocytes
    271. Ala/Ala genotype of Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-γ2 gene is associated with obesity and insulin resistance in Asian …
    272. Ala54Thr polymorphism of fatty acid binding protein 2, role on insulin resistance and cardiovascular risk factors in presurgical morbid obesity patients
    273. Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat
    274. Alcohol intake, insulin resistance, and abdominal obesity in elderly men
    275. All-trans-retinoic acid represses obesity and insulin resistance by activating both peroxisome proliferation-activated receptor β/δ and retinoic acid receptor
    276. Allelic Variant Gly1057 Asp of IRS-2 Gene Has Distinctive Effects on insulin Secretion and Sensitivity in obesity and Type 2 Diabetes
    277. Allicin ameliorates obesity comorbid depressive-like behaviors: involvement of the oxidative stress, mitochondrial function, autophagy, insulin resistance and NOX …
    278. Allograft Inflammatory Factor-1 Deficiency Prevents obesity and insulin Resistance by Promoting Brown and Beige Adipocyte Thermogenic Programs
    279. ALOX5AP expression, but not gene haplotypes, is associated with obesity and insulin resistance
    280. ALOX5AP overexpression in adipose tissue leads to LXA4 production and protection against diet-induced obesity and insulin resistance
    281. Alström syndrome: an ultra-rare monogenic disorder as a model for insulin resistance, type 2 diabetes mellitus and obesity
    282. Alström syndrome: renal findings in correlation with obesity, insulin resistance, dyslipidemia and cardiomyopathy in 38 patients prospectively evaluated at the NIH …
    283. Alteration of gut microbiota by vancomycin and bacitracin improves insulin resistance via glucagon‐like peptide 1 in diet‐induced obesity
    284. Alteration of JNK-1 signaling in skeletal muscle fails to affect glucose homeostasis and obesity-associated insulin resistance in mice
    285. Alteration of lipid metabolism and insulin secretion in ventromedial hypothalamic obesity rats
    286. Alteration of local adipose tissue trace element homeostasis as a possible mechanism of obesity-related insulin resistance
    287. Alterations in hepatic mitochondrial compartment in a model of obesity and insulin resistance
    288. Alterations in Novel Signals in the Gut–Adipose Axis–A Pilot Study in insulin-Resistant Children with obesity and Biopsy-Proven Nonalcoholic Steatohepatitis
    289. Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes.
    290. Alterations in the hepatic insulin receptor kinase in genetic and acquired obesity in rats
    291. Alterations in the liver of intrauterine growth retarded piglets may predispose to development of insulin resistance and obesity in later life
    292. Alterations in vitamin A/retinoic acid homeostasis in diet-induced obesity and insulin resistance
    293. Alterations of carbohydrate and lipoprotein metabolism in childhood obesity–impact of insulin resistance and acanthosis nigricans.
    294. Alterations of mitochondrial function and insulin sensitivity in human obesity and diabetes mellitus
    295. Alterations of Serum True insulin in Patients with Simple obesity and Analyses of Factors Affecting insulin Resistance [J]
    296. Alterations of the classic pathway of complement in adipose tissue of obesity and insulin resistance
    297. Altered adrenocorticotropin and cortisol secretion in abdominal obesity: implications for the insulin resistance syndrome
    298. Altered amino acid concentrations in NAFLD: impact of obesity and insulin resistance
    299. Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance
    300. Altered circulating levels of retinol binding protein 4 and transthyretin in relation to insulin resistance, obesity, and glucose intolerance in Asian Indians
    301. Altered Expression of miR-181a-5p and miR-23a-3p Is Associated With obesity and TNFα-Induced insulin Resistance
    302. Altered Expression of miR-181a-5p and miR-23a-3p Is Associated With obesity and TNFα-Induced insulin Resistance
    303. Altered hypothalamic leptin, insulin, and melanocortin binding associated with moderate-fat diet and predisposition to obesity
    304. Altered insulin response to an acute bout of exercise in pediatric obesity
    305. Altered insulin-Dependent Brain Glucose Metabolism During obesity Depends On Specific Brain Areas
    306. Altered interleukin-10 signaling in skeletal muscle regulates obesity-mediated inflammation and insulin resistance
    307. Altered lipid metabolism associated with insulin resistance and obesity is a major contributor to the onset and progression of type 2 diabetes
    308. Altered plasma insulin and glucose after obesity-producing bipiperidyl brain lesions
    309. Altered temporal changes in Ser312-phosphofetuin-A concentrations in response to a glucose challenge in a mouse model of diet-induced obesity and insulin …
    310. Altering adipocyte metabolism as a way to counteract obesity and insulin Resistance
    311. Alternative M2 activation of Kupffer cells by PPARδ ameliorates obesity-induced insulin resistance
    312. Alzheimer’s disease risk, obesity and tau: is insulin resistance guilty?
    313. Ambient air pollution exaggerates adipose inflammation and insulin resistance in a mouse model of diet-induced obesity
    314. Amelioration of insulin requirement in patients undergoing duodenal bypass for reasons other than obesity implicates foregut factors in the pathophysiology of type II …
    315. Amelioration of obesity-associated inflammation and insulin resistance in c57bl/6 mice via macrophage polarization by fish oil supplementation
    316. Ameliorative effect of low-dose spironolactone on obesity and insulin resistance is through replenishment of estrogen in ovariectomized rats
    317. Aminotransferase activity in morbid and uncomplicated obesity: predictive role of fasting insulin
    318. Aminotransferase and gamma-glutamyl transpeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome
    319. Amniotic fluid insulin concentration as a predictor of obesity.
    320. AMP-activated protein kinase (AMPK): does this master regulator of cellular energy state distinguish insulin sensitive from insulin resistant obesity?
    321. AMP-activated protein kinase α1 protects against diet-induced insulin resistance and obesity
    322. AMP-activated protein kinase α1 protects against diet-induced insulin resistance and obesity. Diabetes 2012; 61: 3114–3125
    323. AMPK activation by metformin suppresses abnormal extracellular matrix remodeling in adipose tissue and ameliorates insulin resistance in obesity
    324. AMPK β1 deletion reduces appetite, preventing obesity and hepatic insulin resistance
    325. An 8-week high-fat diet induces obesity and insulin resistance with small changes in the muscle transcriptome of C57BL/6J mice
    326. An abnormality of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovary syndrome due to coexistent obesity
    327. An Analysis of the Relationships Among obesity, Plasma insulin, and Hepatic Lipogenic Enzymes in
    328. An animal model of gestational obesity and prediabetes: HISS-dependent insulin resistance induced by a high sucrose diet in Sprague Dawley rats.
    329. An anti-inflammatory sterol decreases obesity-related inflammation-induced insulin resistance and metabolic dysregulation
    330. An evaluation of acylated ghrelin and obestatin levels in childhood obesity and their association with insulin resistance, metabolic syndrome, and oxidative stress
    331. An Exploration of relationships between three main characteristics of Equine Metabolic Syndrome, obesity, insulin resistance, and laminitis
    332. An extract of Urtica dioica L. mitigates obesity induced insulin resistance in mice skeletal muscle via protein phosphatase 2A (PP2A)
    333. An In Vivo Screen for Genes Involved in Central Nervous System Control of obesity Identifies Diacylglycerol Kinase as a Regulator of insulin Secretion
    334. An in vivo screen for neuronal genes involved in obesity identifies Diacylglycerol kinase as a regulator of insulin secretion
    335. An individual participant data meta-analysis on metabolomics profiles for obesity and insulin resistance in European children
    336. An insertional polymorphism of the proopiomelanocortin gene is associated with fasting insulin levels in childhood obesity
    337. An investigation into the effects of aspalathin on myocardial glucose transport using cardiomyocytes from control and obesity-induced insulin resistant rats, and …
    338. An investigation of the association between obesity, acanthosis nigricans, and fasting serum insulin level in 6-9 year old children living on the El Paso-Juarez United …
    339. An obesity genetic risk score predicts risk of insulin resistance among Chinese children
    340. An obesity risk SNP (rs17782313) near the MC4R gene is associated with cerebrocortical insulin resistance in humans
    341. An update on immune dysregulation in obesity‐related insulin resistance
    342. An Update to the WISP-1/CCN4 Role in obesity, insulin Resistance and Diabetes
    343. Analysis of data on insulin resistance from the European group for the study of insulin resistance: focus on obesity and hypertension
    344. Analysis of FTO gene variants with obesity and glucose homeostasis measures in the multiethnic insulin Resistance Atherosclerosis Study cohort
    345. Analysis of metabolic profiles underlying surrogates for obesity and insulin resistance in young adults from the Western Australian Pregnancy Cohort (Raine) Study
    346. Analysis of the HepG2/erythrocyte glucose transporter locus in a family with type 2 (non-insulin-dependent) diabetes and obesity
    347. ANALYSIS OF THE IMPACT OF obesity ON insulin-SENSITIVITY AND METABOLIC ABNOMALITY IN TYPE 2 DIABETES MELLITUS [J]
    348. Analysis of three glucose transporter genes in a Caucasian population: no associations with non‐insulin‐dependent diabetes and obesity
    349. Androgen receptor roles in insulin resistance and obesity in males: the linkage of androgen-deprivation therapy to metabolic syndrome
    350. Androgenicity and obesity are independently associated with insulin sensitivity in postmenopausal women
    351. ANDROLOGY: obesity, insulin RESISTANCE AND THEIR CORRELATION WITH TESTOSTERONE LEVELS IN MALE PATIENTS
    352. Angiogenesis and vascular functions in modulation of obesity, adipose metabolism, and insulin sensitivity
    353. Angiogenesis modulates obesity and insulin sensitivity
    354. Angiogenic Potential, Circulating Angiogenic Factors and insulin Resistance in Subjects with obesity
    355. Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance
    356. Angiopoietin-related growth factor antagonizes obesity and insulin resistance
    357. Angiotensin II type 1 receptor-independent beneficial effects of telmisartan on dietary-induced obesity, insulin resistance and fatty liver in mice
    358. Angiotensin-converting enzyme inhibition reverses diet-induced obesity, insulin resistance and inflammation in C57BL/6J mice
    359. Angiotensinogen gene polymorphism (Met235Thr) influences visceral obesity and insulin resistance in obese Japanese women
    360. Anhydroicaritin improves diet-induced obesity and hyperlipidemia and alleviates insulin resistance by suppressing SREBPs activation
    361. Anorexigenic lipopeptides ameliorate central insulin signaling and attenuate tau phosphorylation in hippocampi of mice with monosodium glutamate-induced obesity
    362. Anthocyanin‐rich Black Elderberry Extract improves Inflammatory Markers and insulin Resistance in a High‐Fat Diet‐Induced obesity Model of Mice
    363. Anthropometric measures of obesity and insulin resistance in Turkish patients with type 2 diabetes
    364. Anti-diabetic and anti-obesity effects of the allosteric PTP1B inhibitor KY-226 via insulin and leptin signal enhancement
    365. Anti-inflammatory effects of yerba maté extract (Ilex paraguariensis) ameliorate insulin resistance in mice with high fat diet-induced obesity
    366. Anti-obesity and anti-insulin resistance effects of tomato vinegar beverage in diet-induced obese mice
    367. Anti-obesity and insulin-sensitising effects of a glycosaminoglycan mix
    368. Anti-obesity effects of a mixture of thiamin, arginine, caffeine, and citric acid in non-insulin dependent diabetic KK mice
    369. Anti-obesity effects of DHA and EPA in high fat-induced insulin resistant mice
    370. Anti‐obesity action of gingerol: effect on lipid profile, insulin, leptin, amylase and lipase in male obese rats induced by a high‐fat diet
    371. Anti‐obesity and anti‐diabetic effects of carteolol in non‐insulin‐dependent diabetic mice
    372. Antihypertensive drugs and insulin resistance in obesity
    373. Antioxidant supplementation and obesity have independent effects on hepatic oxylipin profiles in insulin-resistant, obesity-prone rats
    374. Antioxidants protect against diabetes by improving glucose homeostasis in mouse models of inducible insulin resistance and obesity
    375. Antipsychotic drug-induced obesity in rats: correlation between leptin, insulin and body weight during sulpiride treatment
    376. Anxa2 gene silencing attenuates obesity-induced insulin resistance by suppressing the NF-κB signaling pathway
    377. Apelin, a newly identified adipokine up-regulated by insulin and obesity
    378. Apolipoprotein C3 deficiency results in diet-induced obesity and aggravated insulin resistance in mice
    379. Apolipoprotein C3-deficiency results in diet-induced obesity and insulin resistance in mice
    380. Apolipoproteins do not add prognostic information beyond lipoprotein cholesterol measures among individuals with obesity and insulin resistance syndromes: the …
    381. Appearance of acanthosis nigricans may precede obesity: an involvement of the insulin/IGF receptor signaling pathway
    382. Appetite-Regulating Hormones Are Reduced After Oral Sucrose vs Glucose: Influence of obesity, insulin Resistance, and Sex
    383. Appetite, hunger and obesity as a function of dietary sugar intake: Can these effects be mediated by insulin-induced hypoglycemia? A reply to commentaries
    384. APPL1 counteracts obesity-induced vascular insulin resistance and endothelial dysfunction by modulating the endothelial production of nitric oxide and endothelin-1 …
    385. Application of nuclear techniques in the prevention of degenerative diseases (obesity and non-insulin dependent diseases) in ageing
    386. Appropriate use of stimulation tests and insulin-like growth factor-I in obesity.
    387. Are insulin Hypersecretion and Food Additives a Cause of obesity and Diabetes?
    388. Are obesity-related insulin resistance and type 2 diabetes autoimmune diseases?
    389. Are obesity-related metabolic risk factors modulated by the degree of insulin resistance in adolescents?
    390. Are racial differences in obesity and insulin resistance related to aggressive breast cancer?
    391. Are racial differences in obesity and insulin resistance related to aggressive breast cancer?
    392. Are racial differences in obesity and insulin resistance related to aggressive breast cancer?
    393. Arsenic methylation capacity and obesity are associated with insulin resistance in obese children and adolescents
    394. Artemisia scoparia extract attenuates non-alcoholic fatty liver disease in diet-induced obesity mice by enhancing hepatic insulin and AMPK signaling independently of …
    395. Arterial insulin resistance in Yucatan micropigs with diet-induced obesity and metabolic syndrome
    396. Arterial stiffening, insulin resistance and acanthosis nigricans in a community sample of adolescents with obesity
    397. Aryl hydrocarbon receptor agonist indigo protects against obesity-related insulin resistance through modulation of intestinal and metabolic tissue immunity
    398. Assess the relationship between insulin fasting levels and healthy obesity in adults in the province of Babylon, Iraq
    399. Assessing associations of cardiorespiratory fitness (CRF) and degree of obesity with insulin-resistance.
    400. ASSESSING obesity AND insulin MOLECULAR PATHWAYS INVOLVED IN WEIGHT LOSS INDUCED BY ROUX-EN-Y GASTRIC BYPASS
    401. Assessing risk factors for obesity between childhood and adolescence: I. Birth weight, childhood adiposity, parental obesity, insulin, and leptin
    402. Assessing risk factors for obesity between childhood and adolescence. I. Birth weight, childhood adiposity, parental obesity, insulin, and leptin.
    403. Assessing the Mediating Effect of obesity-Linked SNPs in Nuclear Mitochondrial Genes on Exercise-Enhanced insulin Sensitivity
    404. Assessment of different bariatric surgeries in the treatment of obesity and insulin resistance in mice
    405. Assessment of different bariatric surgeries in the treatment of obesity and insulin resistance in mice
    406. Assessment of different bariatric surgeries in the treatment of obesity and insulin resistance in mice.
    407. Assessment of obesity, dyslipidemia, and insulin resistance in idiopathic hirsutism: a case–control study
    408. Assessment of the relationship of hepatic enzymes with obesity and insulin resistance in adults in Saudi Arabia
    409. Assisted reproductive technologies predispose to insulin resistance and obesity in male mice challenged with a high-fat diet
    410. Association between 14 bp insertion/deletion HLA‐G functional polymorphism and insulin resistance in a cohort of Italian children with obesity
    411. Association Between Anthropometric Measures of obesity and insulin Resistance in a Self-Selected Group of Indigenous Australians
    412. Association between caries, obesity and insulin resistance in Mexican adolescents
    413. Association between Caries, obesity and insulin Resistance in Mexican Adolescents.
    414. Association between complement component C3 and body composition: a possible obesity inflammatory biomarker for insulin resistance
    415. Association between cortisol, insulin resistance and zinc in obesity: A mini-review
    416. Association between dietary insulin index and load with obesity in adults
    417. Association between duration of obesity and risk of non-insulin-dependent diabetes mellitus: the Sotetsu Study
    418. Association Between Expanded Normal Weight obesity and insulin Resistance Among US Adults in the National Health and Nutrition Examination Survey
    419. Association between four adipokines and insulin sensitivity in patients with obesity, type 1 or type 2 diabetes mellitus, and in the general Chinese population
    420. Association between G-protein beta3 subunit (GNB (3)) gene C825T polymorphism, hypertension, insulin resistance and obesity
    421. Association between muscle mass and insulin sensitivity independent of detrimental adipose depots in young adults with overweight/obesity
    422. Association between obesity and insulin resistance with UCP2–UCP3 gene variants in Spanish children and adolescents
    423. Association between obesity history and hand grip strength in older adults—exploring the roles of inflammation and insulin resistance as mediating factors
    424. Association between obesity indices and insulin resistance among healthy Korean adolescents: the JS high school study
    425. Association between obesity phenotypes of insulin resistance and risk of type 2 diabetes in African Americans: The Jackson Heart Study
    426. Association between polymorphisms of insulin and insulin receptor gene with childhood obesity in Malay population
    427. Association between Serum Lipid Profile and insulin Resistance in Type 2 Diabetic Patients with obesity [J]
    428. Association between Transcription Factor AP-2B genotype, obesity, insulin resistance and dietary intake in a longitudinal birth cohort study
    429. Association of abdominal obesity, insulin resistance, and oxidative stress in adipose tissue in women with polycystic ovary syndrome
    430. #VALUE!
    431. Association of adipocytokines with obesity and insulin resistance in Korean-Chinese and Han nationality pupils of Yanbian area
    432. Association of adipocytokines with obesity and insulin resistance in Korean-Chinese and Han nationality pupils of Yanbian area
    433. Association of adipokines and insulin, which have a role in obesity, with colorectal cancer
    434. Association of Adipokines and insulin, Which Have a Role in obesity, with Colorectal Cancer
    435. Association of ADRB1 and UCP3 gene polymorphisms with insulin sensitivity but not obesity
    436. Association of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancer
    437. Association of central obesity and insulin resistance with high prevalence of diabetes and cardiovascular disease in an elderly population with low fat intake and lower …
    438. Association of extracellular heat shock protein 70 and insulin resistance in type 2 diabetes; independent of obesity and C-reactive protein
    439. Association of fasting blood sugar level, insulin level, and obesity with left ventricular mass in healthy children and adolescents: The Bogalusa Heart Study
    440. Association of free fatty acids with the insulin-resistant state but not with central obesity in individuals from Venezuela.
    441. Association of gene polymorphism of the fat-mass and obesity-associated gene with insulin resistance in Japanese
    442. Association of gene polymorphism of the fat-mass and obesity-associated gene with insulin resistance in Japanese
    443. Association of gut microbiome with fasting triglycerides, fasting insulin and obesity status in Mexican children
    444. Association of hepatitis C with insulin resistance and type 2 diabetes in US general population: the impact of the epidemic of obesity
    445. Association of insulin Actions with Blood Pressure in Rodent Models of obesity and Diabetes
    446. Association of insulin actions with blood pressure in rodent models of obesity and diabetes.
    447. Association of insulin resistance and GLP-2 secretion in obesity: a pilot study
    448. Association of insulin resistance and obesity with impaired immune response to нepatitis B vaccination in health care workers
    449. ASSOCIATION OF insulin RESISTANCE AND obesity WITH IMPAIRED IMMUNE RESPONSE TO НЕРАTITIS B VACCINATION IN HEALTH CARE WORKERS
    450. Association of insulin resistance with obesity in children
    451. Association of interleukin-6, C-reactive protein, interleukin-10 and adiponectin plasma concentrations with measures of obesity, insulin sensitivity and glucose …
    452. Association of leisure time physical activity and abdominal obesity with fasting serum insulin and 2‐h postchallenge plasma glucose levels
    453. Association of leptin and insulin with childhood obesity and retinal vessel diameters
    454. Association of Leptin Gene G2548A Polymorphism and Leptin Resistance with insulin Resistance and obesity among Egyptians
    455. Association of Leptin With obesity and insulin Resistance
    456. Association of Markers of obesity with insulin Resistance and Type 2 Diabetes Mellitus in a Rural Female Population
    457. Association of miR-34a and mir-149 with obesity and insulin Resistance in Obese Children and Adolescents
    458. Association of MMP‐8 with obesity, smoking and insulin resistance
    459. Association of monocyte CCR2 expression with obesity and insulin resistance in postmenopausal women
    460. Association of nerve conduction impairment and insulin resistance in children with obesity
    461. Association of non-alcoholic fatty liver disease with metabolic syndrome independently of central obesity and insulin resistance
    462. Association of nonalcoholic fatty liver disease with obesity and insulin resistance
    463. Association of obesity and hyperandrogenemia with insulin resistance in women with polycystic ovary syndrome
    464. Association of obesity and insulin resistance with asthma and aeroallergen sensitization
    465. Association of obesity and insulin resistance with dyslipidemia in Indian women with polycystic ovarian syndrome
    466. Association of obesity and insulin resistance with dyslipidemia in Indian women with polycystic ovarian syndrome
    467. Association of obesity and insulin resistance with serum testosterone, sex hormone binding globulin and estradiol in older males
    468. #VALUE!
    469. Association of obesity and overweight with the prevalence of insulin resistance, pre-diabetes and clinical–biochemical characteristics among infertile Mexican women …
    470. Association of obesity indexes of waist circumference, body mass index and WHR with insulin resistance in non-diabetic subjects
    471. Association of obesity risk SNPs in PCSK1 with insulin sensitivity and proinsulin conversion
    472. Association of obesity-mediated insulin resistance and hypothalamic volumes: Possible sex differences
    473. Association of obesity, diabetes, serum lipids and blood pressure regulates insulin action
    474. Association of osteocalcin with obesity, insulin resistance, and cardiovascular risk factors in young adults
    475. Association of osteoprotegerin with obesity, insulin resistance and non-alcoholic fatty liver disease in children
    476. Association of osteosarcopenic obesity and its components: osteoporosis, sarcopenia and obesity with insulin resistance
    477. #VALUE!
    478. Association of Peptic Ulcer Disease with obesity, Serum insulin Level and Lipid Profile
    479. Association of perilipin and insulin receptor substrate-1 genes polymorphism with lipid profiles, central obesity, and type 2 diabetes in a sample of an Iranian …
    480. Association of plasminogen activator inhibitor-1 with insulin resistance in Japan where obesity is rare
    481. Association of Polymorphism in the Glucocorticoid Recepter Gene and Plasm Glucose, insulin, Lipids in Abdominal obesity
    482. Association of Resistin Gene 3′-Untranslated Region EX4-44G–> A Polymorphism with obesity-and insulin-Related Phenotypes in Turkish Type 2 Diabetes …
    483. Association of resistin gene 3′-untranslated region EX4-44G–> A polymorphism with obesity-and insulin-related phenotypes in Turkish type 2 diabetes patients.
    484. Association of serum ferritin and abdominal obesity and insulin resistance
    485. Association of serum ferritin with insulin resistance, abdominal obesity, and metabolic syndrome in Korean adolescent and adults: The Korean National …
    486. #VALUE!
    487. Association of serum leptin and adiponectin with anthropomorphic indices of obesity, blood lipids and insulin resistance in a Sub-Saharan African population
    488. Association of serum leptin levels with homeostasis model assessment–estimated insulin resistance and metabolic syndrome: the key role of central obesity
    489. Association of single nucleotide polymorphism at position 45 in adiponectin gene with plasma adiponectin level and insulin resistance in obesity
    490. Association of sleep apnea severity and obesity with insulin resistance, C-reactive protein, and leptin levels in male patients with obstructive sleep apnea
    491. Association of sleep disturbances with obesity, insulin resistance and the metabolic syndrome
    492. Association of SNP45 in adiponectin gene with obesity and insulin resistance
    493. Association of TCF7L2 and GCG gene variants with insulin secretion, insulin resistance, and obesity in new-onset diabetes
    494. Association of the C825T polymorphism of the G-protein β3 subunit gene with hypertension, obesity, hyperlipidemia, insulin resistance, diabetes, diabetic …
    495. Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity
    496. Association of the TG polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes
    497. Association of the TNF‐α−308 G/A Promoter Polymorphism with insulin Resistance in obesity
    498. Association of the− 243A> G,+ 61450C> A Polymorphisms of the Glutamate Decarboxylase 2 (GAD2) Gene with obesity and insulin Level in North Indian …
    499. #VALUE!
    500. Association of Trp64Arg polymorphism of beta3-adrenergic receptor with insulin resistance in Polish children with obesity.
    501. Association of vitamin B12 with obesity, overweight, insulin resistance and metabolic syndrome, and body fat composition; primary care-based study
    502. Association of β2-adrenergic receptor and insulin receptor substrate-1 polymorphisms with obesity in a Northern Indian population
    503. Associations between Body Fat Measurement by Dual-Energy X-Ray Absorptiometry and Abdominal obesity and insulin Resistance in Korean Populations: Cross …
    504. Associations between estimated fatty acid desaturase activities in serum lipids and adipose tissue in humans: links to obesity and insulin resistance
    505. Associations between insulin sensitivity, and free fatty acid and triglyceride metabolism independent of uncomplicated obesity
    506. Associations between long self-reported sleep, obesity and insulin resistance in a cohort of premenopausal Black and White South African women
    507. Associations between sleep duration and insulin resistance in European children and adolescents considering the mediating role of abdominal obesity
    508. Associations of 25-hydroxyvitamin D with markers of inflammation, insulin resistance and obesity in black and white community-dwelling adults
    509. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women
    510. Associations of cardiac structure with obesity, blood pressure, inflammation, and insulin resistance in African-American adolescents
    511. Associations of chronic inflammation, insulin resistance, and severe obesity with mortality, myocardial infarction, cancer, and chronic pulmonary disease
    512. Associations of fibroblast growth factor-23 with markers of inflammation, insulin resistance and obesity in adults
    513. Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis
    514. Associations of obesity markers, insulin, and sex hormones with HDL-cholesterol levels in Turkish and German individuals
    515. Associations of obesity-metabolic Status With insulin Resistance and Chronic Inflammation Level: Results From the CNTR Study
    516. Associations of physical activity and fitness with hepatic steatosis, liver enzymes, and insulin resistance in children with overweight/obesity
    517. Associations of sarcopenic obesity with the metabolic syndrome and insulin resistance over five years in older men: The Concord Health and Ageing in Men Project
    518. Associations of Serum Fatty Acid Proportions with obesity, insulin Resistance, Blood Pressure, and Fatty Liver: The Cardiovascular Risk in Young Finns Study
    519. Associations of the PTEN− 9C> G polymorphism with insulin sensitivity and central obesity in Chinese
    520. Associations of vitamin D with insulin resistance, obesity, type 2 diabetes, and metabolic syndrome
    521. Astaxanthin restricts weight gain, promotes insulin sensitivity and curtails fatty liver disease in mice fed a obesity-promoting diet
    522. AT1 receptor blockade attenuates insulin resistance and myocardial remodeling in rats with diet-induced obesity
    523. ATF7 ablation prevents diet-induced obesity and insulin resistance
    524. Atorvastatin improves insulin sensitivity in mice with obesity induced by monosodium glutamate
    525. ATP-Binding Cassette Transporter A1 (ABCA 1) Expression in Adipose Tissue and Its Modulation with insulin Resistance in obesity [Corrigendum]
    526. ATP-Binding Cassette Transporter A1 (ABCA 1) Expression in Adipose Tissue and Its Modulation with insulin Resistance in obesity [Corrigendum]
    527. ATP-binding cassette transporter A1 (ABCA1) expression in adipose tissue and its modulation with insulin resistance in obesity
    528. Attenuated insulin induced dilation in coronary arteries from obesity resistant and obesity prone high fat fed rats (1071.6)
    529. Attenuated secretion of glucose-dependent insulinotropic polypeptide (GIP) does not alleviate hyperphagic obesity and insulin resistance in ob/ob mice
    530. Attenuated secretion of glucose-dependent insulinotropic polypeptide (GIP) does not alleviate hyperphagic obesity and insulin resistance in ob/ob mice
    531. Attenuation of Diet-Induced obesity, Hypertension and insulin Resistance in Vascular Endothelial Endothelin-1 Knockout Mice
    532. Attenuation of obesity and insulin resistance by fish oil supplementation is associated with improved skeletal muscle mitochondrial function in mice fed a high-fat diet
    533. Attenuation of obesity-induced insulin resistance in mice with heterozygous deletion of ROCK2
    534. Attenuation of obesity, insulin resistance, and inflammation in TLR4 deficient 10ScN mice in response to a diet high in saturated fat
    535. Atypical PKC: a target for treating insulin-resistant disorders of obesity, the metabolic syndrome and type 2 diabetes mellitus
    536. Augmentation of alimentary insulin secretion despite similar gastric inhibitory peptide (GIP) responses in juvenile obesity
    537. Augmented insulin and leptin resistance of high fat diet-fed APPswe/PS1dE9 transgenic mice exacerbate obesity and glycemic dysregulation
    538. Aurantio‐obtusin improves obesity and insulin resistance induced by high‐fat diet in obese mice
    539. Authors’ response: Associations of obesity and circulating insulin and glucose with breast cancer risk
    540. Autoimmune activation of the GnRH receptor induces insulin resistance independent of obesity in a female rat model
    541. Autologous subcutaneous adipose tissue transplants improve adipose tissue metabolism and reduce insulin resistance and fatty liver in diet‐induced obesity rats
    542. Autonomic Blockade Improves obesity-Associated insulin Resistance
    543. Autonomic neuropathy in non‐insulin dependent (type II) diabetes mellitus. Possible influence of obesity
    544. Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine
    545. Autophagy: a potential link between obesity and insulin resistance
    546. AUTOTAXIN IS NUTRITIONALLY REGULATED AND ALTERS MITOCHONDRIAL FUNCTION IN obesity-INDUCED insulin RESISTANCE
    547. Autotaxin-LPA signaling contributes to obesity-induced insulin resistance in muscle and impairs mitochondrial metabolism
    548. Avocatin B Protects Against Lipotoxicity and Improves insulin Sensitivity in Diet‐Induced obesity
    549. B Cell Activation in insulin Resistance and obesity
    550. B lymphocyte stimulator (BLyS) is a novel adipokine in humans in vivo being related to obesity but not to insulin resistance
    551. B lymphocyte stimulator (BLyS) is expressed in human adipocytes in vivo and is related to obesity but not to insulin resistance
    552. B Lymphocyte Stimulator (BLyS) is expressed in human adipocytes in vivo and is related to obesity but not to insulin resistance
    553. B Lymphocytes in obesity-related adipose tissue inflammation and insulin resistance
    554. b3-adrenergic-receptor polymorphism: a genetic marker for visceral fat obesity and the insulin resistance syndrome
    555. B64 EFFECTS OF obesity ON LUNG FUNCTION: insulin Excess Leads To Lung Remodeling And Features Of Asthma
    556. Baccharis dracunculifolia methanol extract enhances glucose-stimulated insulin secretion in pancreatic islets of monosodium glutamate induced-obesity model rats
    557. Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation
    558. Baicalin against obesity and insulin resistance through activation of AKT/AS160/GLUT4 pathway
    559. Basal insulin and obesity
    560. Basis of Impaired Coronary Metabolic Dilation in obesity and insulin Resistance
    561. Bax inhibitor-1 deficiency leads to obesity by increasing Ca2+-dependent insulin secretion
    562. Behavior of C-peptide and immunoreactive insulin in essential obesity
    563. Beneficial effect of oral administration of Lactobacillus casei strain Shirota on insulin resistance in diet‐induced obesity mice
    564. Beneficial effects of ethanol consumption on insulin resistance are only applicable to subjects without obesity or insulin resistance; drinking is not necessarily a …
    565. Beneficial effects of exercise on offspring obesity and insulin resistance are reduced by maternal high-fat diet
    566. Beneficial effects of exercise on offspring obesity and insulin resistance are reduced by maternal high-fat diet
    567. Beneficial effects of IKKε-deficiency on body weight and insulin sensitivity are lost in high fat diet-induced obesity in mice
    568. Beneficial effects of murtilla extract and madecassic acid on insulin sensitivity and endothelial function in a model of diet-induced obesity
    569. Beneficial Effects of vitamin D on insulin sensitivity, blood pressure, abdominal subcutaneous fat thickness, and weight loss in refractory obesity
    570. Beneficial Effects of Vitamin D on insulin Sensitivity, Blood Pressure, Abdominal Subcutaneous Fat Thickness, and Weight Loss in Refractory obesity
    571. Beneficial metabolic effects of selected probiotics on diet‐induced obesity and insulin resistance in mice are associated with improvement of dysbiotic gut microbiota
    572. Beta-endorphin, insulin, ACTH and cortisol plasma levels during oral glucose tolerance test in obesity after weight loss
    573. Biallelic mutations in GPD1 gene in a Chinese boy mainly presented with obesity, insulin resistance, fatty liver, and short stature
    574. Bif-1 deficiency impairs lipid homeostasis and causes obesity accompanied by insulin resistance
    575. Bile acid alterations in nonalcoholic fatty liver disease, obesity, insulin resistance and type 2 diabetes: what do the human studies tell?
    576. Bilirubin reduces visceral obesity and insulin resistance by suppression of inflammatory cytokines
    577. Binding and molecular weight properties of the insulin receptor from omental and subcutaneous adipocytes in human obesity
    578. Bioactive insulin-like growth factor-I in obesity
    579. Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: Relationships with obesity and insulin resistance
    580. Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: relationships with obesity and insulin resistance
    581. Bioavailable insulin-like growth factor-I as mediator of racial disparity in obesity-relevant breast and colorectal cancer risk among postmenopausal women
    582. Biochemical characteristics and risk factors for insulin resistance at different levels of obesity
    583. Biochemical Effects of Anti-Diabetic Therapies on obesity and insulin Resistance Induced by Monosodium Glutamate in Male Rats
    584. Biochemical studies of cutaneous damage in mouse models of insulin resistance and obesity
    585. #VALUE!
    586. Biocompounds attenuating the development of obesity and insulin resistance produced by a high-fat sucrose diet
    587. Biomarkers of Alzheimer disease, insulin resistance, and obesity in childhood
    588. Bisphenol A and diabetes, insulin resistance, cardiovascular disease and obesity: controversy in a (plastic) cup?
    589. Bisphenol-A plasma levels are related to inflammatory markers, visceral obesity and insulin-resistance: a cross-sectional study on adult male population
    590. BITC and S-carvone restrain high-fat diet-induced obesity and ameliorate hepatic steatosis and insulin resistance
    591. Black yeast beta glucan for insulin Resistance Prevention through IL-33, ST2 and Leptin Level: An In vivo Study of an obesity model using Sprague dawley Rats
    592. Blockade of class IB phosphoinositide-3 kinase ameliorates obesity-induced inflammation and insulin resistance
    593. Blockade of gastric inhibitory polypeptide (GIP) action as a novel means of countering insulin resistance in the treatment of obesity-diabetes
    594. Blockade of tumor necrosis factor (TNF) receptor type 1-mediated TNF-α signaling protected Wistar rats from diet-induced obesity and insulin resistance
    595. Blocking CD40-TRAF6 Signaling is a Novel Therapeutic Target in obesity-Associated insulin Resistance
    596. Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance
    597. Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance (Proceedings of the National Academy of Sciences of the United States …
    598. Blocking CXCR7-mediated adipose tissue macrophages chemotaxis attenuates insulin resistance and inflammation in obesity
    599. Blocking gp130 signaling suppresses autotaxin expression in adipocytes and improves insulin sensitivity in diet-induced obesity
    600. Blocking high-fat diet-induced obesity, insulin resistance and fatty liver by overexpression of Il-13 gene in mice
    601. Blood coagulation and aortic wall integrity in rats with obesity-induced insulin resistance
    602. Blood glucose level and insulin resistance in patients with type 2 diabetic mellitus, diabetic retinopathy and obesity
    603. Blood insulin levels during oral glucose tolerance tests in the obese child. Influence of age, sex, degree and duration of obesity
    604. Blood pressure in 15 inbred mouse strains and its lack of relation with obesity and insulin resistance in the progeny of an NZO/HILtJ× C3H/HeJ intercross
    605. Blood pressure in relation to obesity, insulin and the hypothalamic-pituitary-adrenal axis in Swedish men
    606. Blood sugar and immunoreactive insulin in women with hypothalamic, maternal and simple obesity. Part I.
    607. Blood viscosity in human obesity: relation to glucose tolerance and insulin status.
    608. Blueberries Improve Whole‐Body insulin Action and Alter the Development of obesity in High‐Fat Fed Mice
    609. Body Composition and its Association with insulin Resistance in Korea Older Population: A Focus on Sarcopenic obesity
    610. Body fat distribution and insulin resistance: beyond obesity in nonalcoholic fatty liver disease among overweight men
    611. Body mass index-independent inflammation in omental adipose tissue associated with insulin resistance in morbid obesity
    612. Both insulin signaling defects in the liver and obesity contribute to insulin resistance and cause diabetes in irs2–/–mice
    613. Botryosphaeran reduces obesity, hepatic steatosis, dyslipidaemia, insulin resistance and glucose intolerance in diet-induced obese rats
    614. Brain and behavioral correlates of insulin resistance in youth with depression and obesity
    615. Brain insulin and obesity: From Man to C. elegans
    616. #VALUE!
    617. Brain PPAR-γ promotes obesity and is required for the insulin–sensitizing effect of thiazolidinediones
    618. Brain-Specific Disruption of the Maternal (but not Paternal) Allele of the Imprinted G [sub s] α Gene Leads to obesity and insulin Resistance.
    619. Breastmilk with a high omega‐6 to omega‐3 fatty acid ratio induced cellular events similar to insulin resistance and obesity in 3T3‐L1 adipocytes
    620. Bromocriptine inhibits the seasonally occurring obesity, hyperinsulinemia, insulin resistance, and impaired glucose tolerance in the Syrian hamster, Mesocricetus …
    621. Brown adipose tissue activity as a target for the treatment of